| Literature DB >> 27863510 |
Abstract
BACKGROUND: "Invertebrate defensins" belong to the cysteine-stabilized alpha-beta (CS-αβ), also known as the scorpion toxin-like, superfamily. Some other peptides belonging to this superfamily of defensive peptides are indistinguishable from "defensins," but have been assigned other names, making it unclear what, if any, criteria must be met to qualify as an "invertebrate defensin." In addition, there are other groups of defensins in invertebrates and vertebrates that are considered to be evolutionarily unrelated to those in the CS-αβ superfamily. This complicates analyses and discussions of this peptide group. This paper investigates the criteria for classifying a peptide as an invertebrate defensin, suggests a reference cysteine array that may be helpful in discussing peptides in this superfamily, and proposes that the superfamily (rather than the name "defensin") is the appropriate context for studying the evolution of invertebrate defensins with the CS-αβ fold.Entities:
Keywords: Antimicrobial peptide; CS-αβ superfamily; Fungal defensin; Invertebrate defensin; Invertebrate immunity; Plant defensin; Scorpion toxin
Mesh:
Substances:
Year: 2016 PMID: 27863510 PMCID: PMC5116183 DOI: 10.1186/s13104-016-2291-0
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Landmark papers in identification and establishment of the CS-αβ superfamily
| Year identified | Peptide name, source, and significance | #C | Antimicrobial activity | References |
|---|---|---|---|---|
| 1985 | Charybdotoxin from | 6 | G+, G−, Y | [ |
| 1985 | Defensins from human neutrophils, similar to peptides isolated from rabbit neutrophils | 6 | G+, G−, Y, V | [ |
| 1988 | Sapecins from | 6 |
| [ |
| 1989 | Phormicins/ | 6 |
| [ |
| 1991 | Establishment of CSH motif in arthropod neurotoxic peptides | 4 | [ | |
| 1992 | RsAFP1/RsAFP2–antifungal peptides from | 8 | RsAFP1: | [ |
| 1993 | Scorpion defensin from | 6 | G+ (G−) | [ |
| 1994 | Defensin from | 6 | G+ | [ |
| 1994 | Drosomycin from | 8 |
| [ |
| 1995 | Establishment of CS-αβ fold by adding third disulphide bond to the CSH motif (study used | [ | ||
| 1996 | MGD-1–defensin 1 from | 8 | G+, G−, F (C), some fragments active against Y and P | [ |
| 1996 | Defensins and mytilins from | 6–8 |
| [ |
| 1996 | ASABF–antibacterial factor from | 8 | G+, G− (F) | [ |
| 1999 | Myticins from | 8 | G+, G−, F (P) | [ |
| 2002 | Ce-ABF2–antibacterial factor 2 from | 8 | G+, G−, Y | [ |
| 2004 | Theromacin from | 10 | G+ (G−, F) | [ |
| 2005 | Plectasin–fungal defensin from | 6 | G+ (G−) | [ |
| 2007 | AdDLP–defensin-like peptide from | 4 | P (G+, G−, F, Y, H) | [ |
| 2009 | Hydramacin from | 8 | G+, G− | [ |
| 2011 | ASABF-related peptide from | 8 | G+, G−, F, Y, H | [ |
| 2012 | Neuromacin and theromacin from | 8–10 | G+, G− | [ |
| 2012 | Micasin–defensin-like peptide from | 6 | G+, G− (F, Y, H) | [ |
| 2013 | Mytimacin -AF from | 10 | G+, G−, Y (H) | [ |
| 2014 | Cremycins–drosomycin-like antifungal peptides from | 6 | Cremycin 5: F, Y (G+, G−, H) Cremycin-15: G+, G− (F, Y) | [ |
Peptides are listed in order of initial identification and description. The activity column lists activity against Gram-positive bacteria (G+), Gram-negative bacteria (G−), filamentous fungi (F), yeast (Y), viruses (V), and protozoa (P), as well as cytotoxic (C) and hemolytic (H) activity. The peptide has the activity shown if the abbreviation is shown without parentheses, and has been tested but not shown to have the activity if shown in parentheses. If a dominant activity has been determined, the abbreviation is shown in italics; any activity not shown has not been tested for that peptide. Additional references that establish activity or structure are included
Fig. 1Names, cysteine patterns, and structures of representative CS-αβ peptides. a Names of representative sequences with accession numbers and alignment of mature peptide to reference array. Cysteines 3, 4, 8, and 9 form the cysteine-stabilized helix (CSH) motif, and cysteines 2 and 6 form a third bond to complete the CS-αβ fold. Alignment of all retrieved sequences to the reference array can be found in Additional file 1: Figure S1. b–m Structures of representative peptides with disulfide bonds shown in bright pink: b Sarcophaga peregrina Sapecin A [PDB: 1L4V], c Leiurus quinquestriatus hebraeus Charybdotoxin [PDB: 2CRD], d Drosophila melanogaster Drosomycin [PDB: 1MYN], e Raphanus sativus RsAFP1 [PDB: 1AYJ], f Centruroides sculpturatus CsEv2 [PDB: 1JZB], g Pseudoplectania nigrella Plectasin [PDB: 1ZFU], h Mytilus galloprovincialis MGD1 [PDB: 1FJN], i Mytilus edulis Mytilin B [PDB: 2EEM], j Ascaris suum ASABF [PDB: 2D56], k Scorpio maurus Maurotoxin [PDB: 1TXM], l Hydra magnipapillata Hydramacin [PDB: 2K35], and m Hirudo medicinalis Theromacin [PDB: 2LN8]. Major taxonomic groups are color-coded: Annelida (dark rose), Arachnida (light orange), Bivalvia (light blue), Cnidaria (light grey), Fungi (light green), Hexapoda (orange), Nematoda (lavender), Plantae (green), and Porifera (dark grey)
Antimicrobial activity of representative CS-αβ peptides
| Species | Name [accession number] | #C | γ-core | Activity | References |
|---|---|---|---|---|---|
|
| Sapecin, Sapecin A [Swiss-Prot: P18313] | 6 | Yes |
| [ |
| Sapecin B [Swiss-Prot: P31529] | 6 | No |
| ||
|
| Phormicin, defensin A [Swiss-Prot: P10891] | 6 | Yes |
| [ |
|
| Royalisin [Swiss-Prot: P17722] | 6 | Yes |
| [ |
|
| Defensin [Swiss-Prot: P36192] | 6 | Yes | G+ | [ |
| Drosomycin [Swiss-Prot: P41964] | 8 | Yes |
| [ | |
|
| Heliomicin [GenBank: ACR78445] | 6 | Yes |
| [ |
|
| Gallerimycin [Swiss-Prot: Q8MVY9] | 6 | Yes | F (G+, G−, Y) | [ |
| Defensin [Swiss-Prot: P85213] | 6 | Yes | F, Y (G+, G−) | [ | |
|
| Scapularisin (Scapularisin 6) [GenBank: AAV74387] | 6 | Yes | G+, F (G−) | [ |
|
| Scapularisin 3 [GenBank: EEC13914] | 6 | Reverse | F (G+, G−) | [ |
|
| Charybdotoxin [Swiss-Prot: P13487] | 6 | Yes | G+, G−, Y | [ |
|
| Defensin [Swiss-Prot: P41965] | 6 | Yes | G+ (G−) | [ |
|
| MGD-1 [Swiss-Prot: P80571] | 8 | Yes | G+, G−, F (C) | [ |
|
| Myticin A [Swiss-Prot: P82103] | 8 | No | G+ (G−, F, P) | [ |
| Myticin B [Swiss-Prot: P82102] | 8 | No | G+, G−, F (P) | ||
|
| Mytilin A [Swiss-Prot: P81612] | 8 | Yes |
| [ |
|
| Mytilin B [GenBank: AAD45013] | 8 | Yes | G+, G−, F | [ |
| Mytilin C [sequence from reference] | 7 | Yes | G+, G− (F, P) | ||
| Mytilin D [GenBank: ACF21701] | 8 | Reverse? | G+, G−, F | ||
| Mytilin G1 [sequence from reference] | 8 | Yes | G+ (G−, F) | ||
|
| ASABF-α [GenBank: BAA89497] | 8 | Yes | G+, G− (F) | [ |
|
| Ce-ABF2 [NCBI Reference Sequence: NP_491252] | 8 | Yes | G+, G−, Y | [ |
|
| ASABF-related peptide [GenBank: CCC55928] | 8 | Yes | G+, G−, F, Y, H | [ |
|
| Cremycin 5 [GenBank: AEM44806] | 6 | Yes | F, Y (G+, G−, H) | [ |
| Cremycin 15 [GenBank: AEM44812] | 6 | Yes | G+, G− (F, Y) | ||
|
| Hydramacin [GenBank: ABE26989] | 8 | Yes | G+, G− | [ |
|
| Neuromacin [Swiss-Prot: A8V0B3] | 8 | Yes | G+, G− | [ |
| Theromacin [Swiss-Prot: A8I0L8] | 10 | Yes | G+, G− | ||
|
| Theromacin [GenBank: AAR12065] | 10 | Yes | G+ (G−, F) | [ |
|
| Mytimacin-AF [GenBank: AFR36920] | 10 | Yes | G+, G−, Y (H) | [ |
|
| RsAFP1 [GenBank: AAA69541] | 8 | Yes |
| [ |
|
| Gamma-2-zeathionin, PDC-1 [Swiss-Prot: P81009] | 8 | Yes | F | [ |
|
| MsDEF1 [GenBank: AAG40321] | 8 | Yes | F | [ |
|
| NaD1 [Swiss-Prot: Q8GTM0] | 8 | Yes | F | [ |
|
| Brazzein [Swiss-Prot: P56552] | 8 | Yes | G+, G−, Y | [ |
|
| Plectasin [Swiss-Prot: Q53I06] | 6 | Yes | G+ (G−) | [ |
|
| Micasin [GenBank: JN014007] | 6 | Yes | G+, G− (F, Y, H) | [ |
|
| Defensin [Swiss-Prot: Q10745] | 6 | Yes | G+ (G−) | [ |
|
|
| 6 | Yes | G+ | [ |
|
| Coprisin [GenBank: ABP97087] | 6 | Yes | G+, G−, Y (H, C) | [ |
|
| Tenecin 1 [Swiss-Prot: Q27023] | 6 | Yes |
| [ |
|
| Longicin [Swiss-Prot: Q58A47] | 6 | Yes | G+, G−, Y, P (H) | [ |
|
| Navidefensin 2-2 [Sequence from reference] | 6 | Yes | G+ (G−, F, Y) | [ |
|
| DLD [GenBank: AK024601] | 6 | No | F (G+, G−, Y) | [ |
Peptides are listed in the order they are discussed in the text. The activity column lists activity against Gram-positive bacteria (G+), Gram-negative bacteria (G−), filamentous fungi (F), yeast (Y), and protozoa (P), as well as cytotoxic (C) and hemolytic (H) activity. The peptide has the activity shown if the abbreviation is shown without parentheses, and has been tested but not shown to have the activity if shown in parentheses. If a dominant activity has been determined, the abbreviation is shown in italics; any activity not shown has not been tested for that peptide
Fig. 2Phylogenetic analyses of 250 CS-αβ peptides. Accession numbers corresponding to the labels in the tree can be found in Additional file 3: Table S2. Bootstrap values greater than 70% are shown in red font; those greater than 50% are shown in orange font. Bootstrap consensus tree of maximum likelihood analysis in MEGA6 using the WAG + G + I model. Numbers reflect the percent support from 1000 bootstrap replicates
Fig. 3Phylogenetic analyses of 250 CS-αβ peptides. Accession numbers corresponding to the labels in the tree can be found in Additional file 3: Table S2. Posterior probabilities greater than 0.7 are shown in red font; those greater than 0.5 are shown in orange font. Bayesian analysis in MrBayes 3.2. Numbers represent posterior probabilities from an analysis with 2,000,000 generations at a temperature parameter of 0.5